2BB score and signals
Contineum Therapeutics, Inc.’s current 2BB score is 31 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 26 | Low |
| Momentum | 57 | Stable |
| Financial strength | 31 | Weak |
| Quality | 69 | Strong |
| Risk | 54 | Moderate |
Contineum Therapeutics, Inc. (CTNM) Stock Score & Signals
Contineum Therapeutics, Inc. (CTNM) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 31 out of 100.
Company facts
| Founded | 2009 |
| Employees | 51 |
| 52-week range | $7.96 – $17.78 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-03 | — | -0.4756 | — | $0.00 |
| 2026-10-28 | — | -0.4641 | — | $0.00 |
| 2026-08-18 | — | -0.4607 | — | $0.00 |
| 2026-05-05 | -0.39 | -0.5421 | $0.00 | $0.00 |